SailPoint, Inc. <SAIL.O>: Barclays Raises Target Price to $21 From $19
SAIL•Related News
Beam Therapeutics names Eric Foster chief commercial officer
BEAM•
Tenax Therapeutics CEO to present at Cantor Global Healthcare Conference
TENX•
Ingram Micro Holding Corporation: Deutsche Bank initiates coverage with hold rating and target price $30
INGM•
Medtronic rises after raising fiscal 2027 forecasts on heart device demand
MDT•
Kazia expands paxalisib trial into HR+/HER2- advanced breast cancer
KZIA•